XML 56 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
Business Segments and Concentrations (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Financial Information
The following tables set forth financial information by segment:
Year Ended December 31, 2024Consumer Products segmentIngredients segmentAnalytical Reference Standards and Services segmentCorporate and otherTotal
(In thousands)
Net sales$76,772 $19,814 $3,011 $— $99,597 
Cost of sales27,478 7,808 2,725 — 38,011 
Gross profit49,294 12,006 286 — 61,586 
Operating expenses:
Sales and marketing:
Advertising 11,102 — — — 11,102 
Marketing 8,346 195 — 8,545 
Selling 9,285 40 497 — 9,822 
Research and development4,782 1,234 — — 6,016 
General and administrative— — — 18,375 18,375 
Operating expenses33,515 1,469 501 18,375 53,860 
Operating income (loss)$15,779 $10,537 $(215)$(18,375)$7,726 
Year Ended December 31, 2023Consumer Products segmentIngredients segmentAnalytical Reference Standards and Services segmentCorporate and otherTotal
(In thousands)
Net sales$69,528 $11,137 $2,905 $— $83,570 
Cost of sales24,755 4,980 3,055 — 32,790 
Gross profit (loss)44,773 6,157 (150)— 50,780 
Operating expenses:
Sales and marketing:
Advertising 10,259 — — — 10,259 
Marketing 7,354 — 10 — 7,364 
Selling 8,401 52 362 — 8,815 
Research and development4,273 685 — — 4,958 
General and administrative— — — 24,983 24,983 
Operating expenses30,287 737 372 24,983 56,379 
Operating income (loss)$14,486 $5,420 $(522)$(24,983)$(5,599)
Schedule of Disaggregation of Revenue Disaggregated revenues are as follows:
Year Ended December 31, 2024Consumer
Products
Segment
Ingredients
Segment
Analytical Reference
Standards and Services Segment
Total
(In thousands)
Tru Niagen®, Consumer Product$76,772 $— $— $76,772 
Food-grade Niagen®
— 17,540 — 17,540 
Pharmaceutical-grade Niagen®
— 1,700 — 1,700 
Subtotal Niagen® Related76,772 19,240 — 96,012 
Other Ingredients— 574 — 574 
Reference Standards— — 2,891 2,891 
Consulting and Other— — 120 120 
Subtotal Other Goods and Services— 574 3,011 3,585 
Total Net Sales$76,772 $19,814 $3,011 $99,597 

Year Ended December 31, 2023Consumer
Products
Segment
Ingredients
Segment
Analytical Reference
Standards and Services Segment
Total
(In thousands)
Tru Niagen®, Consumer Product$69,528 $— $— $69,528 
Food-grade Niagen®— 10,550 — 10,550 
Pharmaceutical-grade Niagen®— — — — 
Subtotal Niagen® Related69,528 10,550 — 80,078 
Other Ingredients— 587 — 587 
Reference Standards— — 2,804 2,804 
Consulting and Other— — 101 101 
Subtotal Other Goods and Services— 587 2,905 3,492 
Total Net Sales$69,528 $11,137 $2,905 $83,570 
Schedule of Revenue from International Sources Net sales from international sources detailed by each business segment are as follows:
Year Ended December 31,
(In millions) 20242023
Consumer Products Segment$19.8 $21.3 
Ingredients Segment3.6 $2.7 
Analytical Reference Standards and Services Segment0.9 $1.0 
Total net sales from international sources $24.3 $25.0 
Schedules of Major Customers and Major Vendor Percentage of revenues from major customers of the Company’s consumer products segment for the years indicated were as follows:
Year Ended December 31,
Major Customers20242023
A.S. Watson Group (1)12.5 %15.4 %
Life Extension11.7 %*
* Represents less than 10%
(1) Customer was classified as a related party for part of the year. See Note 6, Related Party Transactions for further details.

The percentage of the amounts due from major customers to total accounts receivable, net as of the periods indicated were as follows:
As of December 31,
Major Customers20242023
A.S. Watson Group (1)47.6 %52.7 %
Life Extension*16.1 %
Amazon Marketplaces14.3 %12.2 %
Wells Pharma of Houston10.3 %*
* Represents less than 10%
(1) Customer was classified as a related party for part of the year. See Note 6, Related Party Transactions for further details.
The Company’s major vendor who accounted for more than 10% of the Company’s total accounts payable is as follows:
Major VendorAs of December 31,
20242023
Vendor A47.2 %64.3 %